J&J expects to deliver 20 mln doses in U.S. by end of March

At a U.S. House of Representatives hearing on Tuesday, Richard Nettles, Vice President of Medical Affairs at J&J unit Janssen Pharmaceutical, said the company expects to deliver 20 million doses of the vaccine in the U.S. by the end of March.